We are live on ! Find out more
KIN

Kindred Biosciences, Inc.
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

Back to rankings

43 hedge funds and large institutions have $52.4M invested in Kindred Biosciences, Inc. in 2016 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

5% more funds holding

Funds holding: 41 → 43 (+2)

0% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 14

18% less capital invested

Capital invested by funds: $64.1M → $52.4M (-$11.7M)

Holders
43
Holders Change
+2
Holders Change %
+4.88%
% of All Funds
1.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
14
Reduced
14
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$8.6M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$6.34M
3
GIP
Granite Investment Partners
California
+$740K
4
Wells Fargo
Wells Fargo
California
+$565K
5
AI
Ariel Investments
Illinois
+$512K

Top Sellers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
-$15M
2
EC
EcoR1 Capital
California
-$4.17M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$529K
4
SKK
Shepherd Kaplan Krochuk
Massachusetts
-$232K
5
OWIM
Old West Investment Management
California
-$227K
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$110K +$1.81K +374 +1%
BA
27
BlackRock Advisors
Delaware
$99K -$5.81K -1,201 -5%
Acadian Asset Management
28
Acadian Asset Management
Massachusetts
$83K +$87.9K +18,173 +1,252%
Goldman Sachs
29
Goldman Sachs
New York
$74K -$30.3K -6,271 -27%
EAM
30
Evanson Asset Management
California
$70K – – –
LPL Financial
31
LPL Financial
California
$68K -$2.09K -431 -3%
BG
32
BlackRock Group
United Kingdom
$63K – – –
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$58K +$65.8K +13,604 New
Millennium Management
34
Millennium Management
New York
$50K +$56.8K +11,727 New
NFA
35
Nationwide Fund Advisors
Ohio
$45K +$10.2K +2,100 +24%
CG
36
Cutler Group
California
$15K – – –
BIM
37
BlackRock Investment Management
Delaware
$13K – – –
BJ
38
BlackRock Japan
Japan
$9K -$1.92K -396 -15%
TRCT
39
Tower Research Capital (TRC)
New York
$6K +$6.67K +1,379 New
Federated Hermes
40
Federated Hermes
Pennsylvania
$3K +$2.88K +596 New
MA
41
MUFG Americas
New York
$1K -$1.74K -360 -51%
AG
42
Advisor Group
Arizona
$1K +$1.63K +337 New
BG
43
Baupost Group
Massachusetts
– -$15M -3,011,584 Closed
Fidelity Investments
44
Fidelity Investments
Massachusetts
– -$529K -106,458 Closed
OWIM
45
Old West Investment Management
California
– -$227K -45,682 Closed
NFGCM
46
Norman Fields Gottscho Capital Management
New York
– -$69K -13,900 Closed
Bank of Montreal
47
Bank of Montreal
Ontario, Canada
– -$2K -440 Closed
1
2

KIN Hedge Fund Activity: Q4 2016 in Review

43 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q4 2016, worth a combined $52.4M — down 18% from $64.1M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new KIN positions and 5 closed out — a net gain of 2 holders — while 14 added to existing stakes and 14 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $8.6M. The largest seller was Baupost Group, exiting entirely with an estimated $15M sold.

  • 43 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q4 2016, up from 41 in Q3 2016.
  • Funds reported $52.4M of Kindred Biosciences, Inc. stock for Q4 2016, down 18% quarter-over-quarter.
  • 7 funds opened new Kindred Biosciences, Inc. positions in Q4 2016 and 5 closed out, a net change of +2 holders.
  • The largest Kindred Biosciences, Inc. buyer in Q4 2016 was Morgan Stanley, an estimated $8.6M added.
  • The largest Kindred Biosciences, Inc. seller in Q4 2016 was Baupost Group, an estimated $15M sold.

Based on aggregated 13F filings for Q4 2016.